RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 29 10 2018
accepted: 19 03 2019
entrez: 27 4 2019
pubmed: 27 4 2019
medline: 22 9 2020
Statut: epublish

Résumé

Secondary plasma cells (PCs) originate from memory B cells and produce increased levels of antibodies with higher affinity compared to PCs generated during primary responses. Here we demonstrate that virus-like particles (VLPs) only induce secondary PCs in the presence of toll-like receptor (TLR) 7 and if they are loaded with RNA. Furthermore, adoptive transfer experiments demonstrate that RNA and TLR7 signaling are required for secondary PC generation, both at the level of memory B cell as well as PC differentiation. TLR7-signaling occurred in a B cell intrinsic manner as TLR7-deficient B cells in an otherwise TLR7-competent environment failed to differentiate into secondary PCs. Therefore, RNA inside VLPs is essential for the generation of memory B cells, which are competent to differentiate to secondary PCs and for the differentiation of secondary PCs themselves. While we have not tested all other TLR or non-TLR adjuvants with our VLPs, these data have obvious implications for vaccine design, as RNA packaged into VLPs is a simple way to enhance induction of memory B cells capable of generating secondary PCs.

Identifiants

pubmed: 31024563
doi: 10.3389/fimmu.2019.00736
pmc: PMC6467167
doi:

Substances chimiques

Adjuvants, Immunologic 0
Antibodies, Viral 0
TLR7 protein, human 0
Toll-Like Receptor 7 0
Vaccines, Virus-Like Particle 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

736

Références

J Exp Med. 2000 Sep 18;192(6):813-21
pubmed: 10993912
FEBS Lett. 2000 Oct 6;482(3):261-4
pubmed: 11024472
Immunity. 2001 May;14(5):617-29
pubmed: 11371363
Allergy. 2001 Jun;56(6):498-505
pubmed: 11421893
Vaccine. 2002 Aug 19;20(25-26):3104-12
pubmed: 12163261
Intervirology. 2002;45(4-6):212-7
pubmed: 12566703
Immunol Today. 1992 Nov;13(11):431-3
pubmed: 1282319
Expert Rev Vaccines. 2003 Apr;2(2):219-29
pubmed: 12899573
J Immunol. 2004 Feb 1;172(3):1777-85
pubmed: 14734761
J Immunol. 2004 Oct 1;173(7):4308-16
pubmed: 15383559
Nature. 2005 Nov 17;438(7066):364-8
pubmed: 16292312
Nat Rev Immunol. 2006 Oct;6(10):741-50
pubmed: 16977339
J Immunol. 2007 Jan 1;178(1):67-76
pubmed: 17182541
Science. 2006 Dec 22;314(5807):1936-8
pubmed: 17185603
J Immunol. 2007 Feb 15;178(4):2415-20
pubmed: 17277148
J Immunol. 2007 Jun 15;178(12):7779-86
pubmed: 17548615
Eur J Immunol. 2008 Jan;38(1):114-26
pubmed: 18081037
J Exp Med. 2009 Aug 31;206(9):2013-25
pubmed: 19703988
J Immunol. 2009 Sep 15;183(6):3788-99
pubmed: 19710454
J Immunol. 2010 May 1;184(9):4615-9
pubmed: 20368279
Immunity. 2011 Mar 25;34(3):375-84
pubmed: 21353603
J Exp Med. 2012 Mar 12;209(3):597-606
pubmed: 22370719
J Immunol. 2012 Jun 1;188(11):5389-96
pubmed: 22529295
Cell. 2012 Aug 3;150(3):606-19
pubmed: 22819539
Immunol Rev. 2013 Jan;251(1):177-88
pubmed: 23278749
J Immunol. 2014 Jun 15;192(12):5499-508
pubmed: 24821969
Autoimmunity. 2015 Feb;48(1):1-12
pubmed: 25536171
Immunity. 2016 Jan 19;44(1):116-130
pubmed: 26795247
J Immunol. 2016 May 15;196(10):4172-84
pubmed: 27053762
Sci Rep. 2016 Jul 21;6:29063
pubmed: 27439378
Hum Vaccin Immunother. 2017 Jan 2;13(1):19-33
pubmed: 27636098
Immunology. 2017 Mar;150(3):329-342
pubmed: 27861835
J Immunol. 2017 Feb 15;198(4):1595-1605
pubmed: 28077601
J Control Release. 2017 Apr 10;251:92-100
pubmed: 28257987
J Exp Med. 2017 May 1;214(5):1259-1267
pubmed: 28363897
J Immunol. 2017 Jun 1;198(11):4205-4209
pubmed: 28432147
J Exp Med. 2017 Sep 4;214(9):2777-2794
pubmed: 28698287
Curr Opin Immunol. 2017 Aug;47:17-25
pubmed: 28728074
J Immunol. 2018 Feb 1;200(3):937-948
pubmed: 29282308
Front Immunol. 2017 Dec 19;8:1833
pubmed: 29312329
Front Immunol. 2018 Jan 10;8:1938
pubmed: 29367853
Immunity. 2018 Mar 20;48(3):584-598.e5
pubmed: 29548673
J Exp Med. 2018 Apr 2;215(4):1227-1243
pubmed: 29549115
Front Immunol. 2018 Apr 09;9:641
pubmed: 29686670
Nat Immunol. 2018 Aug;19(8):871-884
pubmed: 29988090
Cell. 1987 Mar 13;48(5):757-70
pubmed: 3493076
Mol Immunol. 1987 Jul;24(7):675-97
pubmed: 3498884
Semin Immunol. 1994 Oct;6(5):279-86
pubmed: 7532458
J Virol. 1995 Mar;69(3):1895-902
pubmed: 7853531
Annu Rev Immunol. 1997;15:235-70
pubmed: 9143688
Nature. 1997 Jul 10;388(6638):133-4
pubmed: 9217150

Auteurs

Caroline C Krueger (CC)

Department of BioMedical Research, University of Bern, Bern, Switzerland.
Department of Immunology RIA, University Hospital Bern, Bern, Switzerland.

Franziska Thoms (F)

Department of Dermatology, University Hospital Zurich, Schlieren, Switzerland.

Elsbeth Keller (E)

Department of BioMedical Research, University of Bern, Bern, Switzerland.
Department of Immunology RIA, University Hospital Bern, Bern, Switzerland.

Fabiana M S Leoratti (FMS)

Department of BioMedical Research, University of Bern, Bern, Switzerland.
Department of Immunology RIA, University Hospital Bern, Bern, Switzerland.

Monique Vogel (M)

Department of BioMedical Research, University of Bern, Bern, Switzerland.
Department of Immunology RIA, University Hospital Bern, Bern, Switzerland.

Martin F Bachmann (MF)

Department of BioMedical Research, University of Bern, Bern, Switzerland.
Department of Immunology RIA, University Hospital Bern, Bern, Switzerland.
Nuffield Department of Medicine, The Henry Wellcome Building for Molecular Physiology, The Jenner Institute, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH